ICLR

Icon Plc
Data: 2026-06-03
$143.9
Price
4.62%
Change
$211.00
52W High
$66.57
52W Low

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Quick Stats
Jun 03, 2026

54.0

AI Score

HOLD

1.01

Volume Ratio

Jun 03, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

ICLR Stock Summary

Last updated Jun 03, 2026

ICLR is currently trading at $143.9, positioned below its 200-day moving average of $151.28, suggesting bearish momentum. The stock has a 52-week range of $66.57 to $210.9999.

Technical Analysis: The 50-day moving average stands at $115.36, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.99, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.141, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ICLR at 54.0/100 with a HOLD recommendation.

ICLR (Icon Plc) Indicators

Last updated Jun 03, 2026

Indicator Value
RSI(14) 73.99
CMF (20) 0.141
ROC (10) 26.728
ADX (14) 26.872
Indicator Value
MACD (12,26,9) 6.404
AROONOSC (14) 64.286
WILLAMS %R (14) -5.455
MFI (14) 77.984
ICLR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ICLR Price vs Max Options Open Interest
ICLR Max Change In Options Open Interest

ICLR Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ICLR Daily Out of Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ICLR Daily In the Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ICLR Most Active Options by Volume(near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Icon Plc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ICLR Moving Averages Analysis

Icon Plc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 03, 2026

ICLR (Icon Plc) Simple Moving Averages

Moving Averages are last updated Jun 03, 2026

Days MA
10 127.31
20 123.29
30 119.2
50 115.36
100 125.0
200 151.28

ICLR Fundamental Analysis

P/E (Forward) 13.1752
P/E (Trailing) 47.4276
Market Cap ($) 10.5 billion
Earnings/Share ($) 2.9
Net Proft Margin (%) 0.0278
Dividend/Share ($) --
EPS Estimate Current Year ($) 10.5759
EPS Estimate Next Year ($) 11.7625
WallStreet Target Price ($) 151.6875
Most Recent Quarter